• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AN1

ANAGENICS LIMITED - Announcements

0.00% ! 0.7¢
Market Cap $3.474M  !

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



Filters [Clear]
  • Price Sensitive: Yes
AN1 Appointment of Dr Dominic Burg as Chief Operating OfficerPRICE SENSITIVE01/06/20 download Created with Sketch. 65.5KB
AN1 Suspension from Official QuotationPRICE SENSITIVE11/05/20 download Created with Sketch. 167.03KB
AN1 Trading HaltPRICE SENSITIVE07/05/20 download Created with Sketch. 171.11KB
AN1 Pause in TradingPRICE SENSITIVE07/05/20 download Created with Sketch. 114.21KB
AN1 Appendix 4C and Quarterly Activity ReportPRICE SENSITIVE27/04/20 download Created with Sketch. 264.22KB
AN1 Cellmid's Alopecia Patent Allowed in Australia and JapanPRICE SENSITIVE24/04/20 download Created with Sketch. 137.08KB
AN1 Independent Test Results For The Wondfo SARS-CoV-2 TestPRICE SENSITIVE22/04/20 download Created with Sketch. 77.02KB
AN1 Cellmid's Shipment of SARS-CoV-2 Tests ReceivedPRICE SENSITIVE14/04/20 download Created with Sketch. 61.63KB
AN1 Pause in TradingPRICE SENSITIVE14/04/20 download Created with Sketch. 114.6KB
AN1 Reinstatement to Official QuotationPRICE SENSITIVE07/04/20 download Created with Sketch. 70.86KB
AN1 Cellmid Share Placement Raises $6 MillionPRICE SENSITIVE07/04/20 download Created with Sketch. 72.27KB
AN1 Response to ASX Query LetterPRICE SENSITIVE06/04/20 download Created with Sketch. 662.92KB
AN1 Suspension from Official QuotationPRICE SENSITIVE06/04/20 download Created with Sketch. 177.04KB
AN1 Trading HaltPRICE SENSITIVE02/04/20 download Created with Sketch. 172.74KB
AN1 Reinstatement to Official QuotationPRICE SENSITIVE27/03/20 download Created with Sketch. 71.03KB
AN1 Market Update on COVID-19PRICE SENSITIVE27/03/20 download Created with Sketch. 69.7KB
AN1 Cellmid Signs COVID-19 Rapid Diagnostic Supply AgreementPRICE SENSITIVE27/03/20 download Created with Sketch. 86.33KB
AN1 Suspension from Official QuotationPRICE SENSITIVE24/03/20 download Created with Sketch. 178.81KB
AN1 Trading HaltPRICE SENSITIVE20/03/20 download Created with Sketch. 173.63KB
AN1 Appendix 4D, Half Year Accounts and PresentationPRICE SENSITIVE26/02/20 download Created with Sketch. 3.06MB
AN1 Cellmid's Evolis Patent to be Granted in ChinaPRICE SENSITIVE04/02/20 download Created with Sketch. 70.43KB
AN1 Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE30/01/20 download Created with Sketch. 236.85KB
AN1 Key Midkine Antibody Patents Granted in the US and EuropePRICE SENSITIVE06/01/20 download Created with Sketch. 89.81KB
AN1 Cellmid Reports on QVC SalesPRICE SENSITIVE05/12/19 download Created with Sketch. 93.27KB
AN1 Cellmid Signs Trading Agreement With API/PricelinePRICE SENSITIVE06/11/19 download Created with Sketch. 95.47KB
AN1 Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE23/10/19 download Created with Sketch. 248.37KB
AN1 New TV Shopping Agreement for EvolisPRICE SENSITIVE14/10/19 download Created with Sketch. 89.05KB
AN1 Cellmid Share Placement raises $1.5 millionPRICE SENSITIVE14/10/19 download Created with Sketch. 72.41KB
AN1 Trading HaltPRICE SENSITIVE10/10/19 download Created with Sketch. 130.36KB
AN1 New Evolis Distribution & Supply Agreements - China & EuropePRICE SENSITIVE01/10/19 download Created with Sketch. 103.59KB
AN1 FY2019 Financial ResultsPRICE SENSITIVE28/08/19 download Created with Sketch. 74.43KB
AN1 Appendix 4E and FY19 Financial ReportPRICE SENSITIVE28/08/19 download Created with Sketch. 2.1MB
AN1 Patent for Improved Midkine Antibody Allowed in EuropePRICE SENSITIVE22/08/19 download Created with Sketch. 78.33KB
AN1 CDY Signs Distribution Agreement for EVOLIS in South KoreaPRICE SENSITIVE06/08/19 download Created with Sketch. 102.3KB
AN1 Response to Appendix 4C QueryPRICE SENSITIVE01/08/19 download Created with Sketch. 413.12KB
AN1 Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE26/07/19 download Created with Sketch. 279.33KB
AN1 Response to ASX Aware QueryPRICE SENSITIVE08/07/19 download Created with Sketch. 434.23KB
AN1 Cellmid Sets Another Sales Record in Q4 FY2019PRICE SENSITIVE04/07/19 download Created with Sketch. 93.84KB
AN1 Cellmid's Evolis Registered in European Union (EU)PRICE SENSITIVE30/04/19 download Created with Sketch. 297.58KB
AN1 Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE29/04/19 download Created with Sketch. 739KB
AN1 Minimum Holding Share Buy-BackPRICE SENSITIVE19/03/19 download Created with Sketch. 254.77KB
AN1 Appendix 4D, Half Year Accounts and Strategy UpdatePRICE SENSITIVE21/02/19 download Created with Sketch. 2.1MB
AN1 Significant New Findings Published on MidkinePRICE SENSITIVE07/02/19 download Created with Sketch. 268.65KB
AN1 Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE23/01/19 download Created with Sketch. 549.1KB
AN1 Cellmid Expects Record Sales in Q2 FY2019PRICE SENSITIVE12/12/18 download Created with Sketch. 222.34KB
AN1 Cellmid Appoints Exclusive New Zealand DistributorPRICE SENSITIVE19/11/18 download Created with Sketch. 223.09KB
AN1 New Patents for Midkine Antibodies in USA and EuropePRICE SENSITIVE07/11/18 download Created with Sketch. 226.65KB
AN1 Ikon Legal Action - DecisionPRICE SENSITIVE02/11/18 download Created with Sketch. 199.86KB
AN1 Trading HaltPRICE SENSITIVE02/11/18 download Created with Sketch. 144.58KB
AN1 Cellmid's Evolis Successfully Launched in USA storesPRICE SENSITIVE01/11/18 download Created with Sketch. 227.68KB
AN1 Repayment of R&D LoanPRICE SENSITIVE01/11/18 download Created with Sketch. 206.24KB
AN1 Investor PresentationPRICE SENSITIVE31/10/18 download Created with Sketch. 2.36MB
AN1 Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE15/10/18 download Created with Sketch. 479.22KB
AN1 Lead Antibody Effective in Rare Chronic Kidney DiseasePRICE SENSITIVE12/09/18 download Created with Sketch. 31.77KB
AN1 Cellmid Share Purchase Plan CompletionPRICE SENSITIVE03/09/18 download Created with Sketch. 129.32KB
AN1 Evolis USA Distribution UpdatePRICE SENSITIVE30/08/18 download Created with Sketch. 110.21KB
AN1 Preliminary Final ReportPRICE SENSITIVE24/08/18 download Created with Sketch. 217.28KB
AN1 Cleansing Notice and Appendix 3BPRICE SENSITIVE06/08/18 download Created with Sketch. 387.46KB
AN1 Cellmid Share Purchase PlanPRICE SENSITIVE31/07/18 download Created with Sketch. 149.47KB
AN1 Cellmid Share Placement Raises $9MPRICE SENSITIVE31/07/18 download Created with Sketch. 106.44KB
AN1 Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE31/07/18 download Created with Sketch. 300.39KB
AN1 Trading HaltPRICE SENSITIVE27/07/18 download Created with Sketch. 141.88KB
AN1 CELLMID UPDATES ON DISTRIBUTION OF EVOLISPRICE SENSITIVE11/07/18 download Created with Sketch. 178.82KB
AN1 CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKETPRICE SENSITIVE02/05/18 download Created with Sketch. 182.71KB
AN1 CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLISPRICE SENSITIVE24/04/18 download Created with Sketch. 90.04KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE23/04/18 download Created with Sketch. 114.53KB
AN1 CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINAPRICE SENSITIVE04/04/18 download Created with Sketch. 320.39KB
AN1 Appendix 4D and Half Year AccountsPRICE SENSITIVE22/02/18 download Created with Sketch. 209.54KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE25/01/18 download Created with Sketch. 232.07KB
AN1 RECORD 2M SALES FOR CELLMID FGF5 INHIBITORSPRICE SENSITIVE10/01/18 download Created with Sketch. 63.89KB
AN1 CELLMID QUARTERLY OPERATIONAL UPDATEPRICE SENSITIVE09/01/18 download Created with Sketch. 93.09KB
AN1 CELLMID PLACEMENT TO STRATEGIC INVESTORPRICE SENSITIVE15/12/17 download Created with Sketch. 68.34KB
AN1 CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLISPRICE SENSITIVE07/12/17 download Created with Sketch. 97.36KB
AN1 YPB: Agreement with Cellmid to access Chinese health marketPRICE SENSITIVE28/11/17 download Created with Sketch. 199.4KB
AN1 CELLMID OPENS FIRST CONCEPT STORE IN TOKYOPRICE SENSITIVE26/10/17 download Created with Sketch. 82.25KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE25/10/17 download Created with Sketch. 105.48KB
AN1 PROPOSED CONSOLIDATION OF SECURITIESPRICE SENSITIVE24/10/17 download Created with Sketch. 86.65KB
AN1 Consolidation/Split - CDYPRICE SENSITIVE23/10/17 download Created with Sketch. 25.22KB
AN1 CELLMID RECEIVES $947K R&D TAX CREDITPRICE SENSITIVE03/10/17 download Created with Sketch. 20.35KB
AN1 Appendix 4E and Preliminary Final ReportPRICE SENSITIVE30/08/17 download Created with Sketch. 602.28KB
AN1 CELLMID COMPLETES US CONSUMER STUDYPRICE SENSITIVE21/08/17 download Created with Sketch. 120.25KB
AN1 CELLMID SECURES PREMIUM US RETAIL CHANNEL FOR EVOLISPRICE SENSITIVE03/08/17 download Created with Sketch. 80.66KB
AN1 Chinese Import Permits ReceivedPRICE SENSITIVE01/08/17 download Created with Sketch. 86.07KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE28/07/17 download Created with Sketch. 325.45KB
AN1 Nature Paper MK in MelanomaPRICE SENSITIVE03/07/17 download Created with Sketch. 135.5KB
AN1 Appendix 4C - quarterlyPRICE SENSITIVE19/04/17 download Created with Sketch. 76.34KB
AN1 CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHEDPRICE SENSITIVE02/03/17 download Created with Sketch. 109.33KB
AN1 Cellmid to Refinance R&D Loan FacilityPRICE SENSITIVE01/03/17 download Created with Sketch. 335.81KB
AN1 Appendix 4D and Half Year AccountsPRICE SENSITIVE28/02/17 download Created with Sketch. 464.85KB
AN1 MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCEPRICE SENSITIVE07/02/17 download Created with Sketch. 79.03KB
AN1 CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWEDPRICE SENSITIVE31/01/17 download Created with Sketch. 95.59KB
AN1 Appendix 4CPRICE SENSITIVE24/01/17 download Created with Sketch. 2.09MB
AN1 CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMMEPRICE SENSITIVE18/01/17 download Created with Sketch. 102.46KB
AN1 Cellmid Updates on CxBladder LicensePRICE SENSITIVE12/12/16 download Created with Sketch. 84.33KB
AN1 Cellmid receives 831K R&D tax creditPRICE SENSITIVE29/11/16 download Created with Sketch. 75.44KB
AN1 USA launch of evolis-CDY.AX PRICE SENSITIVE03/11/16 download Created with Sketch. 91.45KB
AN1 USA launch of evolisPRICE SENSITIVE03/11/16 download Created with Sketch. 91.45KB
AN1 ASX Market Release - Reinstatement-CDY.AX PRICE SENSITIVE01/11/16 download Created with Sketch. 81.17KB
AN1 Suspension from Official Quotation-CDY.AX PRICE SENSITIVE28/10/16 download Created with Sketch. 216.76KB
AN1 Trading Halt-CDY.AX PRICE SENSITIVE26/10/16 download Created with Sketch. 221.94KB
AN1 Appointment of Dr Dominic Burg as Chief Operating Officer
01/06/20PRICE SENSITIVE download Created with Sketch. 65.5KB
AN1 Suspension from Official Quotation
11/05/20PRICE SENSITIVE download Created with Sketch. 167.03KB
AN1 Trading Halt
07/05/20PRICE SENSITIVE download Created with Sketch. 171.11KB
AN1 Pause in Trading
07/05/20PRICE SENSITIVE download Created with Sketch. 114.21KB
AN1 Appendix 4C and Quarterly Activity Report
27/04/20PRICE SENSITIVE download Created with Sketch. 264.22KB
AN1 Cellmid's Alopecia Patent Allowed in Australia and Japan
24/04/20PRICE SENSITIVE download Created with Sketch. 137.08KB
AN1 Independent Test Results For The Wondfo SARS-CoV-2 Test
22/04/20PRICE SENSITIVE download Created with Sketch. 77.02KB
AN1 Cellmid's Shipment of SARS-CoV-2 Tests Received
14/04/20PRICE SENSITIVE download Created with Sketch. 61.63KB
AN1 Pause in Trading
14/04/20PRICE SENSITIVE download Created with Sketch. 114.6KB
AN1 Reinstatement to Official Quotation
07/04/20PRICE SENSITIVE download Created with Sketch. 70.86KB
AN1 Cellmid Share Placement Raises $6 Million
07/04/20PRICE SENSITIVE download Created with Sketch. 72.27KB
AN1 Response to ASX Query Letter
06/04/20PRICE SENSITIVE download Created with Sketch. 662.92KB
AN1 Suspension from Official Quotation
06/04/20PRICE SENSITIVE download Created with Sketch. 177.04KB
AN1 Trading Halt
02/04/20PRICE SENSITIVE download Created with Sketch. 172.74KB
AN1 Reinstatement to Official Quotation
27/03/20PRICE SENSITIVE download Created with Sketch. 71.03KB
AN1 Market Update on COVID-19
27/03/20PRICE SENSITIVE download Created with Sketch. 69.7KB
AN1 Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
27/03/20PRICE SENSITIVE download Created with Sketch. 86.33KB
AN1 Suspension from Official Quotation
24/03/20PRICE SENSITIVE download Created with Sketch. 178.81KB
AN1 Trading Halt
20/03/20PRICE SENSITIVE download Created with Sketch. 173.63KB
AN1 Appendix 4D, Half Year Accounts and Presentation
26/02/20PRICE SENSITIVE download Created with Sketch. 3.06MB
AN1 Cellmid's Evolis Patent to be Granted in China
04/02/20PRICE SENSITIVE download Created with Sketch. 70.43KB
AN1 Appendix 4C and Notes to Appendix 4C
30/01/20PRICE SENSITIVE download Created with Sketch. 236.85KB
AN1 Key Midkine Antibody Patents Granted in the US and Europe
06/01/20PRICE SENSITIVE download Created with Sketch. 89.81KB
AN1 Cellmid Reports on QVC Sales
05/12/19PRICE SENSITIVE download Created with Sketch. 93.27KB
AN1 Cellmid Signs Trading Agreement With API/Priceline
06/11/19PRICE SENSITIVE download Created with Sketch. 95.47KB
AN1 Appendix 4C and Notes to Appendix 4C
23/10/19PRICE SENSITIVE download Created with Sketch. 248.37KB
AN1 New TV Shopping Agreement for Evolis
14/10/19PRICE SENSITIVE download Created with Sketch. 89.05KB
AN1 Cellmid Share Placement raises $1.5 million
14/10/19PRICE SENSITIVE download Created with Sketch. 72.41KB
AN1 Trading Halt
10/10/19PRICE SENSITIVE download Created with Sketch. 130.36KB
AN1 New Evolis Distribution & Supply Agreements - China & Europe
01/10/19PRICE SENSITIVE download Created with Sketch. 103.59KB
AN1 FY2019 Financial Results
28/08/19PRICE SENSITIVE download Created with Sketch. 74.43KB
AN1 Appendix 4E and FY19 Financial Report
28/08/19PRICE SENSITIVE download Created with Sketch. 2.1MB
AN1 Patent for Improved Midkine Antibody Allowed in Europe
22/08/19PRICE SENSITIVE download Created with Sketch. 78.33KB
AN1 CDY Signs Distribution Agreement for EVOLIS in South Korea
06/08/19PRICE SENSITIVE download Created with Sketch. 102.3KB
AN1 Response to Appendix 4C Query
01/08/19PRICE SENSITIVE download Created with Sketch. 413.12KB
AN1 Appendix 4C and Notes to Appendix 4C
26/07/19PRICE SENSITIVE download Created with Sketch. 279.33KB
AN1 Response to ASX Aware Query
08/07/19PRICE SENSITIVE download Created with Sketch. 434.23KB
AN1 Cellmid Sets Another Sales Record in Q4 FY2019
04/07/19PRICE SENSITIVE download Created with Sketch. 93.84KB
AN1 Cellmid's Evolis Registered in European Union (EU)
30/04/19PRICE SENSITIVE download Created with Sketch. 297.58KB
AN1 Appendix 4C and Notes to Appendix 4C
29/04/19PRICE SENSITIVE download Created with Sketch. 739KB
AN1 Minimum Holding Share Buy-Back
19/03/19PRICE SENSITIVE download Created with Sketch. 254.77KB
AN1 Appendix 4D, Half Year Accounts and Strategy Update
21/02/19PRICE SENSITIVE download Created with Sketch. 2.1MB
AN1 Significant New Findings Published on Midkine
07/02/19PRICE SENSITIVE download Created with Sketch. 268.65KB
AN1 Appendix 4C and Notes to Appendix 4C
23/01/19PRICE SENSITIVE download Created with Sketch. 549.1KB
AN1 Cellmid Expects Record Sales in Q2 FY2019
12/12/18PRICE SENSITIVE download Created with Sketch. 222.34KB
AN1 Cellmid Appoints Exclusive New Zealand Distributor
19/11/18PRICE SENSITIVE download Created with Sketch. 223.09KB
AN1 New Patents for Midkine Antibodies in USA and Europe
07/11/18PRICE SENSITIVE download Created with Sketch. 226.65KB
AN1 Ikon Legal Action - Decision
02/11/18PRICE SENSITIVE download Created with Sketch. 199.86KB
AN1 Trading Halt
02/11/18PRICE SENSITIVE download Created with Sketch. 144.58KB
AN1 Cellmid's Evolis Successfully Launched in USA stores
01/11/18PRICE SENSITIVE download Created with Sketch. 227.68KB
AN1 Repayment of R&D Loan
01/11/18PRICE SENSITIVE download Created with Sketch. 206.24KB
AN1 Investor Presentation
31/10/18PRICE SENSITIVE download Created with Sketch. 2.36MB
AN1 Appendix 4C and Notes to Appendix 4C
15/10/18PRICE SENSITIVE download Created with Sketch. 479.22KB
AN1 Lead Antibody Effective in Rare Chronic Kidney Disease
12/09/18PRICE SENSITIVE download Created with Sketch. 31.77KB
AN1 Cellmid Share Purchase Plan Completion
03/09/18PRICE SENSITIVE download Created with Sketch. 129.32KB
AN1 Evolis USA Distribution Update
30/08/18PRICE SENSITIVE download Created with Sketch. 110.21KB
AN1 Preliminary Final Report
24/08/18PRICE SENSITIVE download Created with Sketch. 217.28KB
AN1 Cleansing Notice and Appendix 3B
06/08/18PRICE SENSITIVE download Created with Sketch. 387.46KB
AN1 Cellmid Share Purchase Plan
31/07/18PRICE SENSITIVE download Created with Sketch. 149.47KB
AN1 Cellmid Share Placement Raises $9M
31/07/18PRICE SENSITIVE download Created with Sketch. 106.44KB
AN1 Appendix 4C and Notes to Appendix 4C
31/07/18PRICE SENSITIVE download Created with Sketch. 300.39KB
AN1 Trading Halt
27/07/18PRICE SENSITIVE download Created with Sketch. 141.88KB
AN1 CELLMID UPDATES ON DISTRIBUTION OF EVOLIS
11/07/18PRICE SENSITIVE download Created with Sketch. 178.82KB
AN1 CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET
02/05/18PRICE SENSITIVE download Created with Sketch. 182.71KB
AN1 CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS
24/04/18PRICE SENSITIVE download Created with Sketch. 90.04KB
AN1 Appendix 4C - quarterly
23/04/18PRICE SENSITIVE download Created with Sketch. 114.53KB
AN1 CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA
04/04/18PRICE SENSITIVE download Created with Sketch. 320.39KB
AN1 Appendix 4D and Half Year Accounts
22/02/18PRICE SENSITIVE download Created with Sketch. 209.54KB
AN1 Appendix 4C - quarterly
25/01/18PRICE SENSITIVE download Created with Sketch. 232.07KB
AN1 RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS
10/01/18PRICE SENSITIVE download Created with Sketch. 63.89KB
AN1 CELLMID QUARTERLY OPERATIONAL UPDATE
09/01/18PRICE SENSITIVE download Created with Sketch. 93.09KB
AN1 CELLMID PLACEMENT TO STRATEGIC INVESTOR
15/12/17PRICE SENSITIVE download Created with Sketch. 68.34KB
AN1 CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLIS
07/12/17PRICE SENSITIVE download Created with Sketch. 97.36KB
AN1 YPB: Agreement with Cellmid to access Chinese health market
28/11/17PRICE SENSITIVE download Created with Sketch. 199.4KB
AN1 CELLMID OPENS FIRST CONCEPT STORE IN TOKYO
26/10/17PRICE SENSITIVE download Created with Sketch. 82.25KB
AN1 Appendix 4C - quarterly
25/10/17PRICE SENSITIVE download Created with Sketch. 105.48KB
AN1 PROPOSED CONSOLIDATION OF SECURITIES
24/10/17PRICE SENSITIVE download Created with Sketch. 86.65KB
AN1 Consolidation/Split - CDY
23/10/17PRICE SENSITIVE download Created with Sketch. 25.22KB
AN1 CELLMID RECEIVES $947K R&D TAX CREDIT
03/10/17PRICE SENSITIVE download Created with Sketch. 20.35KB
AN1 Appendix 4E and Preliminary Final Report
30/08/17PRICE SENSITIVE download Created with Sketch. 602.28KB
AN1 CELLMID COMPLETES US CONSUMER STUDY
21/08/17PRICE SENSITIVE download Created with Sketch. 120.25KB
AN1 CELLMID SECURES PREMIUM US RETAIL CHANNEL FOR EVOLIS
03/08/17PRICE SENSITIVE download Created with Sketch. 80.66KB
AN1 Chinese Import Permits Received
01/08/17PRICE SENSITIVE download Created with Sketch. 86.07KB
AN1 Appendix 4C - quarterly
28/07/17PRICE SENSITIVE download Created with Sketch. 325.45KB
AN1 Nature Paper MK in Melanoma
03/07/17PRICE SENSITIVE download Created with Sketch. 135.5KB
AN1 Appendix 4C - quarterly
19/04/17PRICE SENSITIVE download Created with Sketch. 76.34KB
AN1 CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHED
02/03/17PRICE SENSITIVE download Created with Sketch. 109.33KB
AN1 Cellmid to Refinance R&D Loan Facility
01/03/17PRICE SENSITIVE download Created with Sketch. 335.81KB
AN1 Appendix 4D and Half Year Accounts
28/02/17PRICE SENSITIVE download Created with Sketch. 464.85KB
AN1 MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCE
07/02/17PRICE SENSITIVE download Created with Sketch. 79.03KB
AN1 CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWED
31/01/17PRICE SENSITIVE download Created with Sketch. 95.59KB
AN1 Appendix 4C
24/01/17PRICE SENSITIVE download Created with Sketch. 2.09MB
AN1 CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMME
18/01/17PRICE SENSITIVE download Created with Sketch. 102.46KB
AN1 Cellmid Updates on CxBladder License
12/12/16PRICE SENSITIVE download Created with Sketch. 84.33KB
AN1 Cellmid receives 831K R&D tax credit
29/11/16PRICE SENSITIVE download Created with Sketch. 75.44KB
AN1 USA launch of evolis-CDY.AX
03/11/16PRICE SENSITIVE download Created with Sketch. 91.45KB
AN1 USA launch of evolis
03/11/16PRICE SENSITIVE download Created with Sketch. 91.45KB
AN1 ASX Market Release - Reinstatement-CDY.AX
01/11/16PRICE SENSITIVE download Created with Sketch. 81.17KB
AN1 Suspension from Official Quotation-CDY.AX
28/10/16PRICE SENSITIVE download Created with Sketch. 216.76KB
AN1 Trading Halt-CDY.AX
26/10/16PRICE SENSITIVE download Created with Sketch. 221.94KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $3.474M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $2.553K 364.7K

Buyers (Bids)

No. Vol. Price($)
2 216436 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 653713 2
View Market Depth
Last trade - 10.26am 11/08/2025 (20 minute delay) ?
Last
0.7¢
  Change
0.000 ( 16.7 %)
Open High Low Volume
0.7¢ 0.7¢ 0.7¢ 18810
Last updated 10.26am 11/08/2025 ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.